Tanyanika Phillips, M.D., M.P.H.
- Lung Cancer
- Geriatric Oncology and Population Health
- Thoracic Geriatric Oncology
- Palliative Care in Advanced Cancer Patients
- Care Management of Vulnerable Populations with Cancer (Populations with Special Needs Elders, Co-morbid Illness, Socially Isolated and Rural Populations)
- Health Care Access
- Decision Making
- Community-Based Participatory Research/Outreach to Achieve Health Equity in Underserved and Rural Populations
- Assistant Clinical Professor, Department of Medical Oncology & Therapeutics Research
- Assistant Clinical Professor, Department of Medical Oncology and Therapeutics City of Hope, Community Network Antelope Valley
- City of Hope Center for Cancer and Aging, Deputy Director of Community Health and Health Equity
- Geriatric Oncology Program Lead, City of Hope Community Network, Antelope Valley
- Research Champion for Clinical Trials, City of Hope Community Network, Antelope Valley
Dr. Phillips received her medical degree from University of Rochester, followed by a geriatric fellowship and a Masters in Public Health from Vanderbilt University. She continued her training with a medical oncology fellowship at Johns Hopkins University.
She wants to improve transparency in clinical research and practice and achieve parity and justice for vulnerable populations with cancer through identification, evaluation, and interventions around cancer health literacy.
She believes vulnerable adults with cancer are older, have limited access to care, may be from underrepresented minority groups, may have food or home insecurity, may be uninsured or under-insured, may have chronic illness, or have limited cancer health literacy.
Serving patients at our Antelope Valley facility, Dr. Phillips hopes to make a difference in the lives of her patients. "I am dedicated to the quality of care for vulnerable adults with cancer," she says, "innovative delivery systems of cancer care and promoting policies that serve to improve cancer care services for vulnerable adults is key to better outcomes for patients.”
Location
Antelope Valley
Lancaster, CA 93534
Education & Experience
2010, American Board of Internal Medicine - Medical Oncology
2001, American Board of Internal Medicine
2004, M.P.H., Population Based Studies/Non-Experimental Design, Vanderbilt University, Nashville, TN
1998, M.D., University of Rochester School of Medicine and Dentistry, Rochester, NY
1993, B.S., Biology, Xavier University of Louisiana, New Orleans, LA
2004-2007, Medical Oncology, Sidney Kimmel Cancer Center at The Johns Hopkins University, Baltimore, MD
2002-2004, K12 Research, Vanderbilt University, Nashville, TN
2001-2002, Geriatric Fellowship, Vanderbilt University, Nashville, TN
1998-2001, Internal Medicine, Ochsner Clinic Foundation, New Orleans, LA
2019-present, Assistant Clinical Professor, Department of Medical Oncology & Therapeutics Research, City of Hope, Lancaster, CA
2019-present, Antelope Valley Medical Center Oncology, Program Director
2015-2019, Medical Oncologist, Christus St. Frances Cabrini Cancer Center, Alexandria, LA
2011-2015, Staff Physician, Hematology Oncology, LaFortune Cancer Center, St John Clinic/MD Anderson Cancer Network Facility, Tulsa, Oklahoma
2007-2011, Assistant Professor, Thoracic Geriatric Oncology, University Hospitals Case Medical Center, Cleveland, Ohio
Awards & Memberships
Awards
2014, Values in Action Champion, Presence, St John Medical Center
2014, Values in Action Champion, Wisdom, St John Medical Center
2012, Values in Action Champion, Human Dignity, St John Medical Center
2011, Unsung Hero Award for Commitment to Community Empowerment and Eliminating Health Care Disparities in Cleveland Ohio
2008-2011, Minority Faculty Development Award, University Hospitals Case Medical Center, Cleveland, OH
2010, Advisory Council Chair Appointment Cleveland Office of Minority Health, Cleveland Department of Health
2008, Certificate of Special Congressional Recognition Kaleidoscope 40/40 Club Young Leaders in Ohio awarded by Congresswoman Stephanie Tubbs Jones
2006-2008, American Society of Clinical Oncology Young Investigator Award funded by the John A Hartford Foundation, “Predicting Treatment Failure in Elderly Patients with Non Small Cell Lung Cancer (NSCLC)” July 1, 2006-June 30, 2007--PI: Tanyanika Phillips, M.D. M.P.H. Total amount of funding: $35,000
2002, American Medical Directors Association Futures Scholar
1998, Ochsner Medical Foundation – Community of Caring Award
1993, Xavier University – Honors in English and Biology
1993, Xavier University – magna cum laude
1990, Xavier University Preparatory – Valedictorian, honors in science and math
Memberships
2016, American Association of Clinical Oncology
Publications
- Towe TP, O'Toole E, Engelhardt K, Nagaiah G, Berger NA. “Changing Health Care Practices for Older Adults with Late Stage Non-Small Cell Lung Cancer (NSCLC): Practical Considerations of Targeted Therapy in Primary Care and Oncology”. J Am Geriatr Soc. 2009 Nov; 57 Suppl 2:S253-8.
- Koroukian SM, Xu F, Bakaki PM, Diaz-Insua M, Towe TP, Owusu C. “Comorbidities, Functional Limitations, and Geriatric Syndromes in Relation to Treatment and Survival Patterns Among Elders With Colorectal Cancer.” J Gerontol A Biol Sci Med Sci. 2009 Dec 16.
- Kypriotakis G, Francis L, O’Toole E, Towe TP, Rose JH. “Preferences for Aggressive Care In Underserved Populations with Advanced-Stage Lung Cancer: Looking Beyond Race and Resuscitation” Supportive Care in Cancer May 2014, Volume 22, Issue 5, pp 1251–1259
- Ferrell BR, Temel JS, Temin S, Alesi ER, Balboni TA, Basch EM, Firn JI, Paice JA, Peppercorn JM, Phillips T, Stovall EL, Zimmermann C, Smith TJ. “Integration of Palliative Care into Standard Oncology Care”: American Society of Clinical Oncology Clinical Practice Guideline Update J Clin Oncol 34 October 31 2016
- Smith CB, Phillips T, Smith TJ. Using the New ASCO Clinical Practice Guideline for Palliative Care Concurrent With Oncology Care Using the TEAM Approach. Am Soc Clin Oncol Educ Book. 2017;37:714-723.
- Brahmer JR, Lacchetti C, Schneider BJ, Atkins MB, Brassil KJ, Caterino JM, Chau I Ernstoff MS, Gardner JM, Ginex P, Hallmeyer S, Holter Chakrabarty J, Leighl NB, Mammen JS, McDermott DF, Naing A, Nastoupil LJ, Phillips T, Porter LD, Puzanov I, Reichner CA, Santomasso BD, Seigel C, Spira A, Suarez-Almazor ME, Wang Y, Weber JS Wolchok JD, Thompson JA. “Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline.” J Clin Oncol. 2018 Feb 14: